Process View
Any process that modulates the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of cell migration involved in sprouting angiogenesis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| JAG1 | jagged 1 | 1.000 | Human | |
| NOTCH1 | notch 1 | 1.000 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.999 | ||
| NOTCH3 | notch 3 | 0.999 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.992 | ||
| NRP1 | neuropilin 1 | 0.909 | ||
| CD247 | CD247 molecule | 0.831 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.820 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.797 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.796 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.688 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.556 | Human | |
| GFI1B | growth factor independent 1B transcription repressor | 0.541 | ||
| LAT | linker for activation of T cells | 0.533 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.484 | ||
| NOTCH2 | notch 2 | 0.463 | Human | |
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.434 | ||
| MEF2C | myocyte enhancer factor 2C | 0.428 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.392 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.364 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.316 | ||
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.279 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.250 | ||
| DLL1 | delta-like 1 (Drosophila) | 0.246 | Human | |
| BCL6 | B-cell CLL/lymphoma 6 | 0.239 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.217 | ||
| JAG2 | jagged 2 | 0.205 | Human | |
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.204 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.192 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.186 | ||
| MAML1 | mastermind-like 1 (Drosophila) | 0.168 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.093 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.090 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.086 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.083 | ||
| PRKD2 | protein kinase D2 | 0.078 | ||
| PDGFC | platelet derived growth factor C | 0.062 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.060 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.058 | Human | |
| PPARA | peroxisome proliferator-activated receptor alpha | 0.057 | ||
| HDAC4 | histone deacetylase 4 | 0.053 | Human | |
| JUN | jun proto-oncogene | 0.053 | ||
| HDAC5 | histone deacetylase 5 | 0.050 | ||
| MEF2A | myocyte enhancer factor 2A | 0.049 | ||
| STC1 | stanniocalcin 1 | 0.048 | ||
| HDAC3 | histone deacetylase 3 | 0.044 | ||
| FOSL2 | FOS-like antigen 2 | 0.043 | ||
| MAPK7 | mitogen-activated protein kinase 7 | 0.042 | ||
| FHL2 | four and a half LIM domains 2 | 0.041 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.035 | ||
| KLF6 | Kruppel-like factor 6 | 0.034 | Human | |
| COL4A1 | collagen, type IV, alpha 1 | 0.033 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.031 | ||
| ASRGL1 | asparaginase like 1 | 0.030 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.028 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.028 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.026 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.025 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.025 | ||
| EGFL7 | EGF-like-domain, multiple 7 | 0.025 | ||
| EHMT2 | euchromatic histone-lysine N-methyltransferase 2 | 0.023 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.023 | ||
| CCDC115 | coiled-coil domain containing 115 | 0.023 | ||
| EFNB2 | ephrin-B2 | 0.021 | ||
| FOXP3 | forkhead box P3 | 0.019 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.018 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.017 | ||
| GABARAP | GABA(A) receptor-associated protein | 0.017 | ||
| SMAD1 | SMAD family member 1 | 0.016 | ||
| LDLR | low density lipoprotein receptor | 0.016 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.016 | ||
| NOTCH2NL | notch 2 N-terminal like | 0.015 | ||
| TRAF7 | TNF receptor-associated factor 7 | 0.015 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.015 | ||
| CTBP1 | C-terminal binding protein 1 | 0.015 | ||
| SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 0.014 | ||
| HDAC7 | histone deacetylase 7 | 0.013 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.013 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.013 | ||
| NID1 | nidogen 1 | 0.012 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.011 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.011 | ||
| WWTR1 | WW domain containing transcription regulator 1 | 0.011 | ||
| THBS1 | thrombospondin 1 | 0.011 | ||
| PRKCQ | protein kinase C, theta | 0.010 | ||
| ITGA6 | integrin, alpha 6 | 0.010 |